Right now, in the right way: U. S. Food and Drug Administration’s expanded access program and patient rights

Ítems similars

• 2276 Development of the expanded access oversight committee at Michigan Medicine
  per: Weatherwax, Kevin, et al.
  Publicat: (2018)
• Access to Investigational Drugs: FDA Expanded Access Programs or “Right‐to‐Try” Legislation?
  per: Holbein, M. E. Blair, et al.
  Publicat: (2015)
• The Critical Role of Medical Institutions in Expanding Access to Investigational Interventions
  per: Spector-Bagdady, Kayte, et al.
  Publicat: (2019)
• Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic
  per: Gravelin, Misty, et al.
  Publicat: (2021)
• The Inherent Unfairness of COVID-19 Drug Access Pathways
  per: Spector-Bagdady, Kayte, et al.
  Publicat: (2020)